We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from our targeted oncology therapies.
Last Closing Price
January 15, 2021
FORDHAM FINANCIAL MANAGEMENT, INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Lantern Pharma, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277